[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 9561 Introduced in House (IH)]

<DOC>






119th CONGRESS
  2d Session
                                H. R. 9561

To direct the Secretary of Health and Human Services to conduct a study 
on the feasibility of developing an accurate and reliable standardized 
test for detecting tuberculosis in tissue from a human cadaver, and for 
                            other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             June 30, 2026

 Mr. Moolenaar (for himself and Mrs. Dingell) introduced the following 
    bill; which was referred to the Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
To direct the Secretary of Health and Human Services to conduct a study 
on the feasibility of developing an accurate and reliable standardized 
test for detecting tuberculosis in tissue from a human cadaver, and for 
                            other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Shandra Eisenga TB Study Act of 
2026''.

SEC. 2. NIH STUDY ON DEVELOPMENT OF STANDARDIZED TUBERCULOSIS TEST FOR 
              HUMAN CADAVER TISSUE.

    (a) Study.--Not later than 2 years after the date of the enactment 
of this Act, the Secretary of Health and Human Services (in this 
section referred to as the ``Secretary'') shall conduct a comprehensive 
study on the feasibility of developing an accurate and reliable 
standardized test, or testing strategy, for detecting tuberculosis in 
tissue from a human cadaver (in this section referred to as a ``TB 
test'') for the purpose of improving donor screening, transplant 
safety, and the integrity of organ and tissue donation systems.
    (b) Consultation.--The Secretary shall conduct the study under 
subsection (a) in consultation with--
            (1) the Director of the National Institutes of Health;
            (2) the Director of the Centers for Disease Control and 
        Prevention;
            (3) the Commissioner of Food and Drugs;
            (4) the Administrator of the Health Resources and Services 
        Administration; and
            (5) relevant stakeholders that have experience with tissue 
        or organ donations and post-mortem systems, including organ 
        procurement organizations and tissue banks.
    (c) Elements.--In conducting the study under subsection (a), the 
Secretary may include, as appropriate--
            (1) assess the current state of scientific knowledge and 
        any research gap related to TB tests;
            (2) evaluate methodologies for testing tissue from a human 
        cadaver;
            (3) consider any issue related to implementing such a 
        methodology with respect to a TB test, including specimen 
        collection, timing requirements for testing, quality assurance, 
        and biosafety;
            (4) assess the feasibility of conducting pilot and 
        implementation studies on TB tests using tissue collected 
        from--
                    (A) individuals across diverse populations, 
                including high-risk and underserved communities; and
                    (B) multiple clinical and tissue recovery sites, 
                including hospitals, organ procurement organizations, 
                tissue banks, and offices of medical examiners;
            (5) develop recommendations for interagency coordination, 
        as appropriate, to support the validation, review, and 
        implementation of a TB test; and
            (6) identify any additional scientific, operational, or 
        regulatory barrier to the development and implementation of a 
        TB test.
    (d) Report.--Not later than 3 years after the date of enactment of 
this Act, the Secretary shall submit to Congress a report describing--
            (1) the findings and conclusions of the Secretary based on 
        the study; and
            (2) a recommendation for developing and implementing a TB 
        test, including any congressional or regulatory action 
        necessary to address any barrier to such development or 
        implementation.
    (e) Funding.--For each of fiscal years 2027 through 2031, the 
Secretary may use amounts appropriated to support the Department of 
Health and Human Services to carry out this section, subject to the 
availability of appropriations.
                                 <all>